Rose Ventures

Xeno Biosciences Inc. is a biopharmaceutical company based in Somerville, Massachusetts, founded in 2015. It specializes in developing innovative therapeutics aimed at addressing unmet needs in obesity and related metabolic diseases. The company's lead product, XEN-101, is an oral formulation designed to replicate the microbiome changes associated with Roux-en-Y Gastric Bypass surgery. By delivering molecular oxygen to the lower gut, Xeno Biosciences enables a shift in the gut microbiome, promoting weight loss without the need for surgical intervention. The company's approach represents a novel class of therapeutics that seeks to transform the treatment landscape for obesity.

CellChorus is a biotechnology company specializing in dynamic, single-cell analysis for biopharmaceutical applications. Its proprietary TIMING™ platform employs visual artificial intelligence to assess cell activation, movement, and killing over time, enhancing the understanding of cellular functions and states. By integrating insights from various analytical methods, including single-cell RNA sequencing and flow cytometry, CellChorus provides healthcare organizations with a comprehensive view of cellular phenotypes and interactions. This technology supports the development of immuno-oncology therapies and other biopharmaceutical innovations, facilitating more effective treatments through a deeper understanding of cell behavior.

Invenra Inc. is a biotechnology company based in Madison, Wisconsin, specializing in the discovery of biologics, particularly focusing on antibodies and their derivatives. Founded in 2011, Invenra employs a proprietary technology that integrates cell-free expression of full-length antibodies with extreme miniaturization. This innovative approach allows for the screening of an unprecedented number of full-length antibodies in phenotypic assays. The company's platform is designed to facilitate the development and optimization of human multi-specific antibodies, with applications in treating diseases such as cancer, Alzheimer's, and diabetes. Invenra's team comprises scientists with extensive expertise across various disciplines, including genomics, biochemistry, and bioengineering, ensuring a strong foundation in both fundamental research and practical applications.

Nira Skin is a brand or line of skincare products. It offers products that include moisturizers, cleansers, toners, serums, and other skincare items. Nira Skin distributes its products across retail, home shopping, direct to consumer, ecommerce, and international channels.

Cellular Dynamics International Inc., (CDI) is a developer and manufacturer of fully functioning cells in industrial quantities to precise specifications. CDI's proprietary products include true human cells in multiple cell types (iCell products), human induced pluripotent stem cells (iPSCs) and custom iPSCs and iCell products (MyCell Products). CDI's products provide standardized, easy-to-use, cost-effective access to the human cell, the smallest fully functioning operating unit of human biology. Customers use our products, among other purposes, for drug discovery and screening, to test the safety and efficacy of their small molecule and biological drug candidates, for stem cell banking, and in the research and development of cellular therapeutics.

Invenra Inc. is a biotechnology company based in Madison, Wisconsin, specializing in the discovery of biologics, particularly focusing on antibodies and their derivatives. Founded in 2011, Invenra employs a proprietary technology that integrates cell-free expression of full-length antibodies with extreme miniaturization. This innovative approach allows for the screening of an unprecedented number of full-length antibodies in phenotypic assays. The company's platform is designed to facilitate the development and optimization of human multi-specific antibodies, with applications in treating diseases such as cancer, Alzheimer's, and diabetes. Invenra's team comprises scientists with extensive expertise across various disciplines, including genomics, biochemistry, and bioengineering, ensuring a strong foundation in both fundamental research and practical applications.